|
Market Closed -
Nasdaq
01:30:00 24/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 3.890 USD | -1.27% |
|
+15.77% | -32.58% |
| 21/10 | Unicycive Therapeutics Shares Rise After FDA Accepts Resubmitted NDA | DJ |
| 21/10 | Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission | CI |
| Market Cap | 11Cr 9.68Cr 8.94Cr 8.1Cr 15Cr 1.03TCr 15Cr 107.57Cr 43Cr 538.93Cr 41Cr 40Cr 1.7TCr | P/E 2026 * |
-3.07x | P/E 2027 * | 2.39x |
|---|---|---|---|---|---|
| Enterprise Value | 11Cr 9.68Cr 8.94Cr 8.1Cr 15Cr 1.03TCr 15Cr 107.57Cr 43Cr 538.93Cr 41Cr 40Cr 1.7TCr | EV / Sales 2026 * |
79.1x | EV / Sales 2027 * | 0.78x |
| Free-Float |
97.74% | Yield 2026 * |
-
| Yield 2027 * | 53.5% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| UNCY | Delayed | |
CBOE
| UNCY | Real-time |
Last Transcript: Unicycive Therapeutics, Inc.
| 1 day | -1.27% | ||
| 1 week | +15.77% | ||
| Current month | -17.15% | ||
| 1 month | -19.13% | ||
| 3 months | -27.96% | ||
| 6 months | -46.64% | ||
| Current year | -32.58% |
| 1 week | 3.36 |  | 4.18 |
| 1 month | 3.35 | | 4.81 |
| Current year | 3.35 | | 8.74 |
| 1 year | 3.35 | | 8.74 |
| 3 years | 2.02 | | 18.18 |
| 5 years | 2.02 | | 31.3 |
| 10 years | 2.02 | | 87.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shalabh Gupta
CEO | Chief Executive Officer | 53 | 18/08/2016 |
John Townsend
DFI | Director of Finance/CFO | 64 | 01/03/2021 |
Guru Reddy
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Shalabh Gupta
CHM | Chairman | 53 | 18/08/2016 |
Sandeep Laumas
BRD | Director/Board Member | 58 | 01/01/2018 |
| Director/Board Member | 58 | 06/09/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/05/26 | Free | Chief Operating Officer | 1,69,500 | 0.6716% | ||
| 14/05/26 | Free | Executive/Senior Manager | 1,69,500 | 0.6716% | ||
| 14/05/26 | Free | Chief Financial Officer | 1,69,500 | 0.6716% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.27% | +15.77% | -24.17% | -46.77% | 11Cr | |
| +2.41% | +0.29% | +39.41% | +72.14% | 6.47TCr | |
| -0.15% | +7.50% | +11.42% | +71.27% | 5.48TCr | |
| +0.57% | +4.60% | +7.71% | +90.93% | 5.35TCr | |
| +0.37% | +4.67% | +26.68% | +49.64% | 4.6TCr | |
| -1.21% | +2.32% | +21.50% | +118.33% | 4.29TCr | |
| -0.37% | +5.07% | +243.23% | +789.58% | 4.01TCr | |
| +0.05% | +0.21% | +18.06% | +48.50% | 3.35TCr | |
| +1.19% | -4.98% | +26.31% | -0.76% | 2.4TCr | |
| -0.38% | +5.68% | +38.39% | +28.35% | 2.37TCr | |
| Average | +0.12% | +3.75% | +40.85% | +122.12% | 3.83TCr | |
| Weighted average by Cap. | +0.39% | +2.73% | +46.00% | +142.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.7L 12.23L 11.3L 10.24L 19.16L 13Cr 19.48L 1.36Cr 53.85L 6.81Cr 51.41L 50.32L 21Cr | 14Cr 12Cr 11Cr 10Cr 19Cr 1.32TCr 20Cr 137.97Cr 55Cr 691.24Cr 52Cr 51Cr 2.18TCr |
| Net income | -3.54Cr -3.16Cr -2.92Cr -2.65Cr -4.95Cr -335.88Cr -5.03Cr -35Cr -14Cr -175.98Cr -13Cr -13Cr -554.81Cr | 5.15Cr 4.6Cr 4.25Cr 3.85Cr 7.21Cr 489.15Cr 7.33Cr 51Cr 20Cr 256.28Cr 19Cr 19Cr 807.99Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | $3.890 | -1.27% | 12,12,426 |
| 22/26/22 | $3.940 | +1.81% | 7,42,888 |
| 21/26/21 | $3.870 | +1.84% | 14,39,444 |
| 20/26/20 | $3.800 | +8.26% | 12,07,934 |
| 19/26/19 | $3.510 | +4.46% | 11,26,561 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UNCY Stock
Select your edition
All financial news and data tailored to specific country editions
